Table of Contents

1.       Research Methodology

2.       Project Scope & Definitions

3.       Executive Summary

4.       Vietnam Pneumococcal Vaccine Market Outlook, 2017-2031F

4.1.    Market Size & Forecast

4.1.1.By Value

4.1.2.By Volume

4.2.    By Type of Vaccine

4.2.1.Live Attenuated Vaccines

4.2.2.Inactivated Vaccines

4.2.3.Subunit Vaccines

4.2.3.1.              Original Pathogen

4.2.3.2.              Polysaccharide Vaccine

4.2.3.3.              Conjugate Vaccine

4.2.3.4.              Protein-based Vaccine

4.2.4.Recombinant Vaccine

4.3.    By Vaccine Property

4.3.1.Adjuvanted

4.3.2.Non-adjuvanted

4.4.    By Route of Administration

4.4.1.Intramuscular

4.4.2.Subcutaneous

4.4.3.Intradermal

4.4.4.Others

4.5.    By Age group

4.5.1.Infants

4.5.2.Children

4.5.3.Adults

4.6.    By End-user

4.6.1.Hospitals

4.6.2.Specialty Clinics

4.6.3.Homecare

4.6.4.Others

4.7.    By Distribution Channel

4.7.1.Hospital

4.7.2.Retail Pharmacy

4.7.3.Online Pharmacy

4.7.4.Non-Governmental Organizations

4.8.    By Region

4.8.1.Northern

4.8.2.Southern

4.8.3.Central

4.9.    By Company Market Share (%), 2023

5.       Market Mapping, 2023

5.1.    By Type of Vaccine

5.2.    By Vaccine Property

5.3.    By Route of Administration

5.4.    By Age group

5.5.    By End-user

5.6.    By Distribution channel

5.7.    By Region

6.       Macro Environment and Industry Structure

6.1.    Supply Demand Analysis

6.2.    Import Export Analysis

6.3.    Value Chain Analysis

6.4.    PESTEL Analysis

6.4.1.Political Factors

6.4.2.Economic System

6.4.3.Social Implications

6.4.4.Technological Advancements

6.4.5.Environmental Impacts

6.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)

6.5.    Porter’s Five Forces Analysis

6.5.1.Supplier Power

6.5.2.Buyer Power

6.5.3.Substitution Threat

6.5.4.Threat from New Entrant

6.5.5.Competitive Rivalry

7.       Market Dynamics

7.1.    Growth Drivers

7.2.    Growth Inhibitors (Challenges and Restraints)

8.       Regulatory Framework and Innovation

8.1.    Clinical Trials

8.2.    Patent Landscape

8.3.    Regulatory Approvals

8.4.    Innovations/Emerging Technologies

9.       Key Players Landscape

9.1.    Competition Matrix of Top Five Market Leaders

9.2.    Market Revenue Analysis of Top Five Market Leaders (in %, 2023)

9.3.    Mergers and Acquisitions/Joint Ventures (If Applicable)

9.4.    SWOT Analysis (For Five Market Players)

9.5.    Patent Analysis (If Applicable)

10.   Pricing Analysis

11.   Case Studies

12.   Key Players Outlook

12.1.     Pfizer Inc.

12.1.1.    Company Details

12.1.2.    Key Management Personnel

12.1.3.    Products & Services

12.1.4.    Financials (As reported)

12.1.5.    Key Market Focus & Geographical Presence

12.1.6.    Recent Developments

12.2.     Merck & Co., Inc.

12.3.     Walvax Biotechnology Co. Ltd.

12.4.     GlaxoSmithKline PLC.

12.5.     PnuVax Incorporated

12.6.     Novartis AG

12.7.     Serum Institute of Vietnam Pvt. Ltd.

12.8.     Panacea Biotec Limited

12.9.     Shenzhen Kangtai Biological Products Co., Ltd

12.10.      Sanofi Pasteur SA

*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

13.   Strategic Recommendations

14. About Us & Disclaimer